Synopsis
Synopsis
0
NDC API
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Eurax
1. 483-63-6
2. N-ethyl-o-crotonotoluidide
3. Trans-crotamiton
4. Crotamitone
5. Eurax
6. Crotalgin
7. 124236-29-9
8. Veteusan
9. Crotamitex
10. Eurasil
11. Euraxil
12. Crotamitonum
13. Crotonyl-n-ethyl-o-toluidine
14. Crotamiton, (e)-
15. 2-butenamide, N-ethyl-n-(2-methylphenyl)-
16. (e)-n-ethyl-n-(2-methylphenyl)but-2-enamide
17. (e)-n-ethyl-n-(o-tolyl)but-2-enamide
18. O-crotonotoluidide, N-ethyl-
19. (2e)-n-ethyl-n-(2-methylphenyl)but-2-enamide
20. 2eeh27851y
21. 2-butenamide, N-ethyl-n-(2-methylphenyl)-, (e)-
22. Mfcd00026989
23. 2-butenamide, N-ethyl-n-(2-methylphenyl)-, (2e)-
24. Nsc-758951
25. Crotan
26. Caswell No. 431b
27. Bestloid
28. Crotamitonum [inn-latin]
29. Smr000059145
30. N-ethyl-n-(2-methylphenyl)but-2-enamide
31. Sr-01000759366
32. Einecs 207-596-3
33. Unii-d6s4o4xd0h
34. Epa Pesticide Chemical Code 055701
35. Chebi:31439
36. Brn 3275497
37. N-ethyl-n-(2-methylphenyl)-2-butenamide
38. Unii-2eeh27851y
39. Ai3-17732
40. N-crotonyl-n-ethyl-o-toluidine
41. (e)-crotamiton
42. Crotamiton [usp:inn:ban:jan]
43. Eurax (tn)
44. Prestwick2_000951
45. Prestwick3_000951
46. N-ethylcrotono-o-toluidide
47. N-ethyl-o-crotonotoluidine
48. G 7857
49. N-ethyl- O-crotonotoluidide
50. D6s4o4xd0h
51. Schembl32934
52. Bspbio_000942
53. Bspbio_002722
54. Crotamiton (jan/usp/inn)
55. 3-12-00-01856 (beilstein Handbook Reference)
56. Mls000759489
57. Mls001424003
58. Mls002222307
59. Mls002695895
60. N-ethyl-ortho-crotonotoluidide
61. Spectrum1505271
62. Bpbio1_001038
63. Component Of Eurax (salt/mix)
64. Chembl1200709
65. Gtpl11165
66. Zinc56427
67. N-ethyl-o-crotonotoluidide, 97%
68. Dtxsid101256463
69. Hms1570p04
70. Hms1922p21
71. Hms2051e10
72. Hms2090a10
73. Hms2093o12
74. Hms2097p04
75. Hms2234e16
76. Hms3714p04
77. Pharmakon1600-01505271
78. Bcp13315
79. Hy-b1177
80. N-ethyl-n-(o-tolyl)but-2-enamide
81. Nsc78382
82. Ccg-39402
83. Nsc-78382
84. Nsc758951
85. S1711
86. (e)-n-ethyl-n-o-tolylbut-2-enamide
87. Akos015892746
88. Cs-4730
89. Nc00107
90. Nsc 758951
91. Ncgc00094571-01
92. Ncgc00094571-02
93. Ncgc00094571-03
94. Ncgc00094571-04
95. Ncgc00094571-05
96. As-11641
97. Trans-n-ethyl-n-(o-tolyl)-2-butenamide
98. Sbi-0206763.p001
99. Ab00513973
100. E0814
101. N-ethyl-n-(2-methylphenyl)-2-butenamide #
102. D01381
103. D70888
104. (2e)-n-ethyl-n-(2-methylphenyl)-2-butenamide
105. Ab00513973-09
106. Ab00513973_10
107. 483c636
108. A827519
109. Q-200893
110. Q2439845
111. Sr-01000759366-4
112. Sr-01000759366-6
113. Brd-k13240564-001-01-8
114. Brd-k57179821-001-05-5
115. Brd-k57179821-001-08-9
116. Crotamiton, British Pharmacopoeia (bp) Reference Standard
117. Crotamiton, European Pharmacopoeia (ep) Reference Standard
118. Crotamiton, United States Pharmacopeia (usp) Reference Standard
119. N-ethyl-o-crotonotoluidide; Crotamitone; Crotalgin; Eurasil; Euraxil
| Molecular Weight | 203.28 g/mol |
|---|---|
| Molecular Formula | C13H17NO |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 3 |
| Exact Mass | 203.131014166 g/mol |
| Monoisotopic Mass | 203.131014166 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 235 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 4 | |
|---|---|
| Drug Name | Crotan |
| PubMed Health | Crotamiton (On the skin) |
| Drug Classes | Scabicide |
| Drug Label | Eurax (crotamiton USP) is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton USP, in a vanishing-cream or emollient-lotion base containing: carbomer-934, cety... |
| Active Ingredient | Crotamiton |
| Dosage Form | Lotion |
| Route | Topical |
| Strength | 10% |
| Market Status | Prescription |
| Company | Summers |
| 2 of 4 | |
|---|---|
| Drug Name | Eurax |
| Active Ingredient | Crotamiton |
| Dosage Form | Lotion; Cream |
| Route | Topical |
| Strength | 10% |
| Market Status | Prescription |
| Company | Ranbaxy |
| 3 of 4 | |
|---|---|
| Drug Name | Crotan |
| PubMed Health | Crotamiton (On the skin) |
| Drug Classes | Scabicide |
| Drug Label | Eurax (crotamiton USP) is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton USP, in a vanishing-cream or emollient-lotion base containing: carbomer-934, cety... |
| Active Ingredient | Crotamiton |
| Dosage Form | Lotion |
| Route | Topical |
| Strength | 10% |
| Market Status | Prescription |
| Company | Summers |
| 4 of 4 | |
|---|---|
| Drug Name | Eurax |
| Active Ingredient | Crotamiton |
| Dosage Form | Lotion; Cream |
| Route | Topical |
| Strength | 10% |
| Market Status | Prescription |
| Company | Ranbaxy |
Pesticides
Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CREAM;TOPICAL - 10%
USFDA APPLICATION NUMBER - 6927
DOSAGE - LOTION;TOPICAL - 10%
USFDA APPLICATION NUMBER - 9112
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Solubilizers
Co-Processed Excipients
Thickeners and Stabilizers
Film Formers & Plasticizers
Direct Compression
API Stability Enhancers
Parenteral
Controlled & Modified Release
Lubricants & Glidants
Rheology Modifiers
Coating Systems & Additives
Emulsifying Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Crotamiton manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crotamiton, including repackagers and relabelers. The FDA regulates Crotamiton manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crotamiton API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Crotamiton manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Crotamiton supplier is an individual or a company that provides Crotamiton active pharmaceutical ingredient (API) or Crotamiton finished formulations upon request. The Crotamiton suppliers may include Crotamiton API manufacturers, exporters, distributors and traders.
click here to find a list of Crotamiton suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Crotamiton DMF (Drug Master File) is a document detailing the whole manufacturing process of Crotamiton active pharmaceutical ingredient (API) in detail. Different forms of Crotamiton DMFs exist exist since differing nations have different regulations, such as Crotamiton USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Crotamiton DMF submitted to regulatory agencies in the US is known as a USDMF. Crotamiton USDMF includes data on Crotamiton's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Crotamiton USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Crotamiton suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Crotamiton Drug Master File in Japan (Crotamiton JDMF) empowers Crotamiton API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Crotamiton JDMF during the approval evaluation for pharmaceutical products. At the time of Crotamiton JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Crotamiton suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Crotamiton Drug Master File in Korea (Crotamiton KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Crotamiton. The MFDS reviews the Crotamiton KDMF as part of the drug registration process and uses the information provided in the Crotamiton KDMF to evaluate the safety and efficacy of the drug.
After submitting a Crotamiton KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Crotamiton API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Crotamiton suppliers with KDMF on PharmaCompass.
A Crotamiton CEP of the European Pharmacopoeia monograph is often referred to as a Crotamiton Certificate of Suitability (COS). The purpose of a Crotamiton CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Crotamiton EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Crotamiton to their clients by showing that a Crotamiton CEP has been issued for it. The manufacturer submits a Crotamiton CEP (COS) as part of the market authorization procedure, and it takes on the role of a Crotamiton CEP holder for the record. Additionally, the data presented in the Crotamiton CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Crotamiton DMF.
A Crotamiton CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Crotamiton CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Crotamiton suppliers with CEP (COS) on PharmaCompass.
A Crotamiton written confirmation (Crotamiton WC) is an official document issued by a regulatory agency to a Crotamiton manufacturer, verifying that the manufacturing facility of a Crotamiton active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Crotamiton APIs or Crotamiton finished pharmaceutical products to another nation, regulatory agencies frequently require a Crotamiton WC (written confirmation) as part of the regulatory process.
click here to find a list of Crotamiton suppliers with Written Confirmation (WC) on PharmaCompass.
Crotamiton Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Crotamiton GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Crotamiton GMP manufacturer or Crotamiton GMP API supplier for your needs.
A Crotamiton CoA (Certificate of Analysis) is a formal document that attests to Crotamiton's compliance with Crotamiton specifications and serves as a tool for batch-level quality control.
Crotamiton CoA mostly includes findings from lab analyses of a specific batch. For each Crotamiton CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Crotamiton may be tested according to a variety of international standards, such as European Pharmacopoeia (Crotamiton EP), Crotamiton JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Crotamiton USP).
LOOKING FOR A SUPPLIER?
